CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation.
|
25066056 |
2014 |
Scoliosis, unspecified
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Our study strongly supports the finding that this recurrent, de novo, variant in NUS1 causes developmental and epileptic encephalopathy with involuntary movement, ataxia and scoliosis.
|
31656175 |
2019 |
Epileptic encephalopathy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Our study strongly supports the finding that this recurrent, de novo, variant in NUS1 causes developmental and epileptic encephalopathy with involuntary movement, ataxia and scoliosis.
|
31656175 |
2019 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Our findings indicate that dosage alteration in particular, of NUS1, EST AI858607, or SLC35F1 are important contributors to the neurodevelopmental phenotype associated with 6q22 deletion, including epilepsy and tremors.
|
24824130 |
2015 |
Myoclonic Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recurrent NUS1 canonical splice donor site mutation in two unrelated individuals with epilepsy, myoclonus, ataxia and scoliosis - a case report.
|
31656175 |
2019 |
Parkinson Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These results suggested that NUS1 mutation may not be a common genetic factor for Chinese patients with sporadic PD.
|
31582230 |
2020 |
B-Cell Lymphomas
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Reverse transcription quantitative polymerase chain reaction assay and Western blot analysis were carried out for the assessment of NgBR, factors correlated to ICAM-1, including steroid receptor coactivator (SRC) and proline-rich tyrosine kinase2 (PYK2), and factors associated with apoptosis, including B-cell lymphoma-2 (Bcl-2), Bcl-2 associated protein X (Bax), caspase 3 and cleaved-caspase 3.
|
31442237 |
2019 |
Congenital Disorders of Glycosylation
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Moreover, we describe a family with a congenital disorder of glycosylation caused by a loss of function mutation in the conserved C terminus of NgBR-R290H and show that fibroblasts isolated from patients exhibit reduced dolichol profiles and enhanced accumulation of free cholesterol identically to fibroblasts from mice lacking NgBR.
|
25066056 |
2014 |
Involuntary Movements
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Our study strongly supports the finding that this recurrent, de novo, variant in NUS1 causes developmental and epileptic encephalopathy with involuntary movement, ataxia and scoliosis.
|
31656175 |
2019 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.
|
30718926 |
2019 |
melanoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.
|
22535842 |
2012 |
Extrapyramidal sign
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
Extrapyramidal sign
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Coding mutations in NUS1 contribute to Parkinson's disease.
|
30348779 |
2018 |
Scoliosis, unspecified
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Epileptic encephalopathy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Autistic Disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|